Advertisement

Topics

Oxford Molecular Group Incorporated Company Profile

18:06 EDT 20th September 2017 | BioPortfolio

Oxford Molecular provides software tools and collaborative research services for identifying and optimizing drug candidates from biological targets. New automated technologies in genomics, high-throughput screening and combinatorial chemistry offer solutions for increasing the quantity and quality of pre-clinical drug candidates. Oxford Molecular helps companies to realize the benefits of these new technologies in the following areas:

Bioinformatics

Cheminformatics

Lead Optimization

Collaborative Research

Bioinformatics



Oxford Molecular is a leading supplier of software solutions for bioinformatics, including data services. Our bioinformatics products include the GCG Wisconsin Package™ and its two interfaces: SeqWeb™ for your web browser, and SeqLab® for X Windows. For the desktop, we offer OMIGA for Windows® and MacVector™ for the Macintosh. We also offer DataServe™, a convenient FTP service allowing pre-formatted downloads of public sequence databases. Finally, there is GENESEQ™ for comprehensive searching of patent sequences obtained from over 40 patent–issuing authorities worldwide.



New bioinformatics products include SeqStore™, which uses an Oracle® framework to integrate public, proprietary and in-house data across your company. Also new is OMIGA-GCG™, which enables users to search and retrieve sequence data from GCG Wisconsin Package databases and then perform sequence analysis within OMIGA’s Windows-based environment.



Cheminformatics



Oxford Molecular’s RS3 Discovery™ is an enterprise-wide research information solution using Oracle. RS3 manages the deluge of data from high-throughput screening and combinatorial chemistry synthesis. It can also assist in rapidly analyzing results and efficiently sharing verified data throughout the organization.



We also offer DIVA, an innovative visual tool for analyzing structures, properties and assay data. DIVA helps identify significant new entities from among thousands of compounds.



Oxford Molecular provides Chem-X™ for combinatorial library registration and lead generation. Its pharmacophore-based tools simplify library comparison and virtual screening.



Lead Optimization



Oxford Molecular helps scientists to discover relationships between molecular structure and activity, understand reactions and interactions between molecules, predict properties of new molecules, determine biological activity and assess toxicity—before expensive laboratory work is undertaken.



CAChe™ is a family of molecular modeling products for Macintosh and Windows desktop computers. Its award-winning user interface lets experimental chemists easily visualize molecules and reactions as well as predict and compare their chemical and physical properties.



For more sophisticated analysis, Oxford Molecular offers a suite of structure-activity programs for SGI workstations:



Tsar™ displays structures and properties in a spreadsheet form and performs a variety of statistical analyses. Tsar can also automatically substitute R-groups to define compounds.

Corina™ converts 2D structures to 3D.

Asp™ automatically aligns molecules for visual comparison.

Topkat® QSTRS provides quantitative assessment of toxicity from structure

Vamp™ performs semi-empirical quantum mechanics calculations to predict a variety of chemical and physical properties.

Collaborative Research



Oxford Molecular’s Collaborative Discovery division uses its expertise in informatics and drug design to accelerate the drug discovery process for clients in pharmaceutical and biotechnology companies. This expertise is complemented by the chemical synthesis skills of Cambridge Combinatorial and the advanced screening capabilities of Cambridge Drug Discovery. As a result, we are able to provide integrated, cost-effective solutions for target identification and validation, lead identification, and lead optimization.



Collaborative Discovery personnel have successfully managed and completed a wide range of multidisciplinary research collaborations. They bring together significant drug discovery experience in industry while also providing access to leading academic institutions through their relationships with key individuals. Our partners experience the benefits of new technologies while saving time and avoiding the cost of developing or supplementing internal resources.



Contact details



For further information, please contact Oxford Molecular:



Europe



Oxford Molecular Group PLC, Medawar Centre, Oxford Science Park, Oxford OX4 4GA, UK; tel: +44 1865 784600; fax: +44 1865 784601; web site http://www.oxmol.co.uk



US



Oxford Molecular Group, Inc., 2105 South Bascom Ave., Suite 200, Campbell, CA 95008, USA; tel: 1-408-879-6300 or 1-800-876-9994; fax: 1-408-879-6302; web site: http://www.oxmol.com

Location

2105 South Bascom Avenue Suite 200
Campbell
CA
95008
United States of America

Contact

Phone: 408 879 6300
Fax: 408 879 6302


News Articles [1931 Associated News Articles listed on BioPortfolio]

#jobs #lifescience Immunocore: Molecular Cell Biologist Target Validation (Scientist) – Oxford, UK

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Immunocore: Molecular Cell Biologist Target Validation (Scientist) – Ox...

#jobs #lifescience Immunocore: Molecular Biologist Single Cell RNA-sequencing (Scientist or Senior Scientist) – Oxford

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Immunocore: Molecular Biologist Single Cell RNA-sequencing (Scientist or Seni...

Oxford Biomedica extends contract with Swiss pharma giant Novartis

Oxford Biomedica (LON:OXB) has extended its partnership with pharmaceutical giant Novartis, signing a new contract for the commercial and clinical supply of its LentiVector gene delivery technology. ...

Sysmex Corporation to Acquire Oxford Gene Technology

Sysmex Corporation (Kobe, Japan), an in vitro diagnostic company, has entered into an agreement to acquire molecular genetics company, Oxford...

Sysmex to acquire Oxford Gene Technology

Oxford Gene Technology (OGT), the molecular genetics company, has signed an agreement to be acquired by Sysmex, a Japanese in vitro diagnostic company.

The University of Oxford’s Materials Department Uses Deben µXCT Stages to Characterise Multiple Engineering and Natural Materials

Deben reports on how the Marrow group in the Materials Department at the University of Oxford applies Deben’s mechanical stage for in situ µXCT studies of multiple engineering and natural ...

GTCR and Carlyle Group are buying Albany Molecular Research for $922 million

Contract drug manufacturer and research company Albany Molecular Research Inc said on Tuesday it agreed to be taken private by buyout firms Carlyle Group LP and GTCR LLC for about $922 million in cash...

Drop ‘complete the course’ message for antibiotics, experts say

Oxford researchers are among a group of infectious disease experts to argue that the advice that patients should complete a course of antibiotics is not supported by evidence and should be dropped. In...

PubMed Articles [5516 Associated PubMed Articles listed on BioPortfolio]

FUNNEL-GSEA: FUNctioNal ELastic-net regression in time-course gene set enrichment analysis.

Gene set enrichment analyses (GSEAs) are widely used in genomic research to identify underlying biological mechanisms (defined by the gene sets), such as Gene Ontology terms and molecular pathways. Th...

Modified Atomic Orbital Overlap: Molecular Level Proof of the Nucleophilic Cleavage Propensity of Dinitrophenol-based Probes.

Out of six possible positional isomers of dinitrophenol, only 2,4-DNP has been used extensively by many researchers for developing reactive molecular probes. But the question remains unanswered: why h...

Effect and its molecular mechanisms of curcumin on pulmonary artery smooth muscle cells in rat model with chronic obstructive pulmonary disease.

Objective: To investigate the effects and the underlying molecular mechanisms of curcumin on pulmonary artery smooth muscle cells in rat model with chronic obstructive pulmonary disease (COPD). Method...

Heat indicators of oxidative stress, inflammation and metal transport show dependence of cadmium pollution history in the liver of female zebrafish.

Environmental stressors such as high temperature and metal exposure may occur sequentially, simultaneously, previously in aquatic ecosystems. However, information about whether responses to high tempe...

Molecular screening of Vel-blood donors using DNA pools in Nanjing of China.

Clinical Trials [4275 Associated Clinical Trials listed on BioPortfolio]

Oxford Partial Knee Replacement. A Randomized Clinical Trial of Three Implant Types

The purpose of this scientific study is to clarify whether there is a relationship between the appearance of radiolucent lines in bone-cement interphase of the tibial component of the diff...

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in th...

Oxford® Partial Knee Kinematics Gait Analysis Study

The objective of this study is to compare the effect on gait of unicompartmental knee arthroplasty (UKA), using the Oxford® Partial Knee, versus total knee arthroplasty (TKA), using the V...

Evaluating Alternative Aftercare Models for Ex-offenders

This study is examining the relative effects of alternative aftercare models for ex-offenders who are recovering from substance abuse/addiction. The study is a longitudinal, randomized fie...

Outcome Analysis of the Oxford Partial Knee Arthroplasty

Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty

Companies [2507 Associated Companies listed on BioPortfolio]

Accelrys, Inc

The software businesses of the Oxford Molecular Group were incorporated into Accelrys Inc. on June 1, 2001.Oxford Molecular was a leading provider of cheminformatics tools. Founded in 1989, Oxford Mol...

Oxford Expression Technologies

Oxford Expression Technologies is a world-renowned centre of excellence for baculovirus protein expression. We provide protein expression products, services and consultancy to many global pharmaceutic...

Oxford Resource Partners, LP

Oxford Resource Partners, LP is a low cost producer of high value steam coal in Northern Appalachia and the Illinois Basin. Oxford markets its coal primarily to large electric utilities with coal-fir...

Oxford Healthcare Technology

Oxford Healthcare Technology is a staffing firm that leverages their recruiting expertise to deliver experienced healthcare professionals and project teams for consulting engageme...

Oxford Lasers, Inc.

Since 1977, Oxford Lasers has been supplying laser solutions to science and industry. Oxford Lasers was founded in 1977 by physicists from Oxford University whose research had been directed towards th...

More Information about "Oxford Molecular Group Incorporated" on BioPortfolio

We have published hundreds of Oxford Molecular Group Incorporated news stories on BioPortfolio along with dozens of Oxford Molecular Group Incorporated Clinical Trials and PubMed Articles about Oxford Molecular Group Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oxford Molecular Group Incorporated Companies in our database. You can also find out about relevant Oxford Molecular Group Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record